Adjusted EBITDA times a multiple gives the enterprise value; the debt, fees, the recoupment escrow and the rollover decide what the owner actually receives.
A podiatry practice is worth its adjusted EBITDA times a multiple, less the debt repaid at closing, with fees, a recoupment escrow and any rollover taken from the equity. In the book's fictional case a platform offered 6.5 times $585,768, an enterprise value of $3,807,492, which left the owner $1,193,049 of cash at closing.
Worked in full in The Podiatry Practice Owner by Julian R. Sterling.Get the DRM-free PDF, $19.99 →or the paperback
Free: the Podiatry Practice Revenue per Visit and Break-Even Calculator, an Excel workbook that returns net collected per honored visit, the contribution per honored visit, the break-even in honored visits a month and per DPM clinic day before and after debt service, and what one more honored visit per DPM clinic day is worth.
A podiatry practice is worth its earnings times a multiple, and the first question is which earnings. Seller's discretionary earnings (SDE) are EBITDA plus the owner's salary and its burden: earnings before any pay to the owner. A DPM who will buy the practice and work in it reads SDE. Adjusted EBITDA is SDE less the cost of a DPM to see the patients the owner sees. A buyer that must pay someone to do that clinical work reads adjusted EBITDA.
In the book's fictional case, Bellcastor Foot and Ankle, that cost is set at $269,445 a year (pay of $230,000 plus burden of 17.15 percent, a case assumption). SDE was $660,440 in FY2025 and $833,155 in FY2026; adjusted EBITDA $390,995 and $563,710. How platforms structure a purchase and what they pay is not covered in this article; the case's letter is one fictional letter, and its multiple is the buyer's figure (to be verified against any real offer).
The trap: an SDE figure multiplied by an EBITDA multiple. The owner's pay is then both added back and still owed to whoever sees her patients. In the case, applying the letter's 6.5 times to SDE of $833,155 instead of to adjusted EBITDA would add $1,608,016 to the value: mostly the pay of a DPM that a buyer must still meet after closing, counted as if it were earnings, less the one-time add-back the letter counts and SDE does not.
On 28 October 2026 a platform of podiatry practices backed by a private equity fund (neither named) sent the owner a letter of intent. Its arithmetic:
| Line | Amount |
|---|---|
| FY2026 EBITDA | $608,227 |
| Add back: the owner's salary and burden | $224,928 |
| SDE | $833,155 |
| Less: cost of a DPM to do the owner's clinical work | −$269,445 |
| Add back: second office pre-opening costs, treated as one-time | $22,058 |
| Adjusted EBITDA | $585,768 |
Enterprise value = $585,768 × 6.5 = $3,807,492, which is 4.57 times SDE (a ratio the buyer does not use)
In the letter, the platform's management company would buy the non-clinical assets and the practice's DPMs would work in a practice entity owned by a DPM under a management agreement, as counsel structures it; whether that structure is open, and who may own a podiatry practice, varies by state (to be verified). The patient records and their custody would stay with the practice entity, never with the management company, as state law sets (varies by state). The letter also leaves to the purchase agreement whether each payer enrollment and contract can pass or must be redone. The owner's own purchase in 2024, which lost $46,322 of collections while plans credentialed her PLLC, shows what that step can cost.
The book goes further: seven Excel workbooks (visits and revenue per visit, associate pay and ramp-up, contribution per visit and break-even, orthotics, diabetic shoes and wound care, second office budget and payback, purchase, transition and SBA loan, offer to cash), each with an exercise and its answer. See The Podiatry Practice Owner · PDF, $19.99
A buyer reads more than one line of earnings. In the case traditional Medicare and Medicare Advantage together were 62.7 percent of what the office visits collected in FY2026, so their rules and audits weigh on the value. The owner sees patients 16 days a month and performs 6 surgical cases a month, more than any associate, and the referral relationships with primary care physicians and wound centers run through her: the owner's own clinic days were 32.0 percent of the first office's DPM clinic days. That is why the letter comes with an employment agreement for her. The second office opened seven months before the letter, which offers an earn-out of up to $250,000 tied to its FY2027 net collections: contingent, and never part of the cash at closing (the article on how an earnout payment is calculated covers the mechanics).
Documentation weighs too. Medicare's Recovery Audit Contractors run complex and automated post-payment reviews to find and collect overpayments. In the case such a review of FY2025 nail debridement claims recouped $14,200 in June 2026, paid from a provision of 1 percent of traditional Medicare and Medicare Advantage collections from office visits that the practice books every month.
A Medicare or Medicaid overpayment is reported and returned within 60 days after it is identified (42 U.S.C. 1320a-7k(d)); a commercial plan's recoupment follows its contract. A buyer therefore asks who bears recoupments on visits billed before closing. The letter holds 4 percent of enterprise value, $152,300, for 18 months, released later only if no claim takes it. In the 2024 purchase the same question cost the seller $18,600 of a $75,000 escrow.
Enterprise value is not what the owner receives. The letter is cash-free and debt-free, with no working capital target: the loans are repaid from the price, fees come off, the escrow is held back and part of the equity is rolled into the buyer.
| Line | Amount |
|---|---|
| Enterprise value | $3,807,492 |
| SBA loan for the purchase repaid | −$1,440,797 |
| SBA loan for the second office repaid | −$234,289 |
| Seller note with accrued interest repaid | −$100,925 |
| Equity value | $2,031,481 |
| Transaction fees (3.5 percent adviser's fee + $45,000 legal) | −$178,262 |
| Recoupment escrow, 4 percent of enterprise value | −$152,300 |
| Rollover, 25 percent of equity value, into the platform's holding company | −$507,870 |
| Cash to the owner at closing | $1,193,049 |
Outside the price, the PLLC keeps its own cash ($280,800), its receivables ($304,228) and its recoupment provision ($13,268). The rollover is equity in the platform's holding company, not in the practice, and is worth what that company is worth when it is sold; the article on how rollover equity is calculated covers the mechanics. Once the bank's loans are repaid, the owner's personal guarantees end with them.
After the sale the owner would be employed by the platform's practice entity as a DPM at $230,000 a year ($269,445 with burden): exactly the cost already deducted from SDE. Her future pay is a cost of the buyer, counted once, neither part of the price nor taken twice. The earnings she gives up each year, SDE less that pay, come to $563,710. Any non-compete in the purchase or employment agreement is a matter of state law; no federal rule governs non-competes since the FTC removed its rule on 12 February 2026.
One turn of multiple moves the owner's cash far more than the price, because the debt does not shrink with it:
| Line | 6.5 times | 5.5 times |
|---|---|---|
| Enterprise value | $3,807,492 | $3,221,724 |
| Debt repaid | $1,776,011 | $1,776,011 |
| Fees | $178,262 | $157,760 |
| Recoupment escrow | $152,300 | $128,869 |
| Rollover | $507,870 | $361,428 |
| Cash at closing | $1,193,049 | $797,656 |
The price fell by 15.4 percent and the cash at closing by 33.1 percent.
An individual buyer financing with a 7(a) loan would face the SBA's SOP 50 10 8.1, effective 1 October 2026: an equity injection of at least 10 percent of total project cost that cannot be reduced, a seller note on full standby for no more than half of it, and coverage of 1.25 to 1; these rules move. On the letter's enterprise value alone, 10 percent is $380,749 and half of that $190,375; the rule's base is the whole project, so the injection required would be higher. That buyer would also price SDE, not adjusted EBITDA, and the lender's coverage test would decide how much of it the loan could carry.
Rules checked on 18 November 2026, federal rules only, and not legal, tax, accounting or clinical advice. Bellcastor Foot and Ankle, its bank, its landlord and the platform that writes to it are fictional: every case figure is a teaching assumption, not a norm. State law is for counsel in the practice's state.
No multiple from the market is given here, because none was verified from a primary source; a buyer sets it from size, growth, the payer mix, the owner's role, surgery and documentation. In the book's fictional letter of intent a platform backed by a private equity fund offered 6.5 times adjusted EBITDA.
A DPM who will work in the practice reads SDE, which adds back the owner's pay. A platform reads adjusted EBITDA, SDE less the cost of a DPM to see the owner's patients. In the case SDE was $833,155 and the buyer's adjusted EBITDA $585,768.
Because the loans are repaid from the price, fees are paid, an escrow is held back for payer recoupments and part of the equity is rolled into the buyer. In the case an enterprise value of $3,807,492 left $1,193,049 of cash at closing, plus a rollover of $507,870.
In the case's letter the records and their custody would stay with the practice entity owned by a DPM, never with the management company; who may hold them, and for how long, is state law and varies by state. Counsel decides.
This article is one chapter's worth of arithmetic from The Podiatry Practice Owner, which follows one fictional two-office foot and ankle practice for 24 months: the purchase with an SBA 7(a) loan and the credentialing transition, traditional Medicare, Medicare Advantage, Medicaid and commercial plans, visits scheduled, honored and billable, charges, allowed amounts and dollars collected, orthotics, diabetic shoes and wound care, surgery and global periods, associates and staff, audits and recoupments, break-even, a second office and a platform's letter of intent taken apart to the owner's cash.
DRM-free PDF, $19.99 · Paperback, $32.99, shipped worldwide · Free calculator